UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Modulation of chemoimmunotherapy efficacy in non-small cell lung cancer by sex and histology: a real-world, patient-level analysis

BMC cancer, 2022-01, Vol.22 (1), p.80-80, Article 80

2022

Link zum Volltext

Verfügbarkeit prüfen

The benefits and harms of adjuvant chemotherapy for non-small cell lung cancer in patients with major comorbidities: A simulation study

PloS one, 2022-11, Vol.17 (11), p.e0263911-e0263911

2022

Link zum Volltext

Verfügbarkeit prüfen

The global burden of lung cancer: current status and future trends

Nature reviews. Clinical oncology, 2023-09, Vol.20 (9), p.624-639

2023

Link zum Volltext

Verfügbarkeit prüfen

Adverse Events Following Limited Resection versus Stereotactic Body Radiation Therapy for Early Stage Lung Cancer

Annals of the American Thoracic Society, 2022-12, Vol.19 (12), p.2053-2061

2022

Link zum Volltext

Verfügbarkeit prüfen

Post-anticoagulant D-dimer is a highly prognostic biomarker of COVID-19 mortality

ERJ open research, 2021-07, Vol.7 (3), p.18

2021

Link zum Volltext

Verfügbarkeit prüfen

Limited Resection Versus Lobectomy for Older Patients With Early-Stage Lung Cancer: Impact of Histology

Journal of clinical oncology, 2015-10, Vol.33 (30), p.3447-3453

2015

Link zum Volltext

Verfügbarkeit prüfen

Comparative Effectiveness of Robotic-Assisted Surgery for Resectable Lung Cancer in Older Patients

Chest, 2020-05, Vol.157 (5), p.1313-1321

2020

Link zum Volltext

Verfügbarkeit prüfen

Outcomes after Stereotactic Body Radiotherapy versus Limited Resection in Older Patients with Early-Stage Lung Cancer

Journal of thoracic oncology, 2015-08, Vol.10 (8), p.1201-1206

2015

Link zum Volltext

Verfügbarkeit prüfen

Benefits and Challenges of Lung Cancer Screening in Older Adults

Clinical therapeutics, 2018-04, Vol.40 (4), p.526-534

2018

Link zum Volltext

Verfügbarkeit prüfen

Outcomes Following SBRT vs. IMRT and 3DCRT for Older Patients with Stage IIA Node-Negative Non-Small Cell Lung Cancer > 5 cm

Clinical lung cancer, 2023-01, Vol.24 (1), p.e9-e18

2023

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy in elderly patients with nonsmall cell lung cancer

Current opinion in pulmonary medicine, 2016-07, Vol.22 (4), p.336-343

2016

Link zum Volltext

Verfügbarkeit prüfen

Atypical hemolytic uremic syndrome associated with Capnocytophaga canimorsus

American journal of hematology, 2017-03, Vol.92 (3), p.322-322

2017

Link zum Volltext

Verfügbarkeit prüfen

The incorporation of cognitive-sparing techniques into prophylactic cranial irradiation in the management of small cell lung cancer

Chinese Clinical Oncology, 2023-08, Vol.12 (4), p.44-44

2023

Link zum Volltext

Verfügbarkeit prüfen

Adverse drug reaction: pomalidomide-induced liver injury

The Lancet (British edition), 2014-06, Vol.383 (9935), p.2125-2126

2014

Link zum Volltext

Verfügbarkeit prüfen

3363 Prognostic Value of Immune-Related Biomarkers in Resected Non-Small Cell Lung Cancer

Journal of clinical and translational science, 2019-03, Vol.3 (s1), p.153-153

2019

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant treatment for elderly patients with early-stage lung cancer treated with limited resection

Annals of the American Thoracic Society, 2013-12, Vol.10 (6), p.622-628

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT048: A Phase II trial of JDQ443 in KRAS G12C- mutated NSCLC with PD-L1 expression <1% or PD-L1 expression≥1% and an STK11 co-mutation

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.CT048-CT048

2023

Link zum Volltext

Verfügbarkeit prüfen

Outcomes following Stereotactic Body Radiotherapy vs. Limited Resection in Older Patients with Early Stage Lung Cancer

Journal of thoracic oncology, 2015-08, Vol.10 (8), p.1201-1206

2015

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Treatment for Elderly Patients with Early Stage Lung Cancer Treated with Limited Resection

Veluswamy, Rajwanth R

2014

Link zum Volltext
ProQuest

Adverse drug reaction: pomalidomide-induced liver injury

Lancet (London, England), 2014, Vol.383 (9935), p.2125-2126

2014

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial of JDQ443 in KRAS G12C -mutated NSCLC with PD-L1 expression <1% or PD-L1 expression ≥1% and an STK11 co-mutation

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS9158-TPS9158

2023

Link zum Volltext

Verfügbarkeit prüfen

Real‐World longitudinal practice patterns in the use of PD‐1 and PD‐L1 inhibitors as First‐Line therapy in patients with Non‐Small cell lung cancer in the United States

Cancer medicine (Malden, MA), 2022-11, Vol.11 (22), p.4265-4272

2022

Link zum Volltext

Verfügbarkeit prüfen

KRAS G12C–Mutant Non–Small Cell Lung Cancer

The Journal of molecular diagnostics : JMD, 2021-05, Vol.23 (5), p.507-520

2021

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Real‐World Data to Investigate the Impact of Race and Ethnicity on Response to Programmed Cell Death‐1 and Programmed Cell Death‐Ligand 1 Inhibitors in Advanced Non‐Small Cell Lung Cancers

The oncologist (Dayton, Ohio), 2021-07, Vol.26 (7), p.e1226-e1239

2021

Link zum Volltext

Verfügbarkeit prüfen

A phase 1b/2 trial of dupilumab given in conjunction with PD-(L)1 blockade in the treatment of relapsed/refractory metastatic NSCLC

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS9139-TPS9139

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(25)

Publikationsform

Sprache

Englisch
(27)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(15)
Humans
(14)
Lung Cancer
(9)
Oncology
(9)
Male
(8)
Aged
(7)
Carcinoma, Non-Small-Cell Lung - Pathology
(7)
Female
(7)
Lung Neoplasms - Pathology
(7)
Chemotherapy
(6)
Neoplasm Staging
(6)
Non-Small Cell Lung Carcinoma
(6)
Cancer
(5)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(5)
Lung Neoplasms - Drug Therapy
(5)
Patients
(5)
Respiratory System
(5)
Cancer Therapies
(4)
Care And Treatment
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Modulation of chemoimmunotherapy efficacy in non-small cell lung cancer by sex and histology: a real-world, patient-level analysis

The benefits and harms of adjuvant chemotherapy for non-small cell lung cancer in patients with major comorbidities: A simulation study

The global burden of lung cancer: current status and future trends

Adverse Events Following Limited Resection versus Stereotactic Body Radiation Therapy for Early Stage Lung Cancer

Post-anticoagulant D-dimer is a highly prognostic biomarker of COVID-19 mortality

Limited Resection Versus Lobectomy for Older Patients With Early-Stage Lung Cancer: Impact of Histology

Comparative Effectiveness of Robotic-Assisted Surgery for Resectable Lung Cancer in Older Patients

Outcomes after Stereotactic Body Radiotherapy versus Limited Resection in Older Patients with Early-Stage Lung Cancer

Benefits and Challenges of Lung Cancer Screening in Older Adults

Outcomes Following SBRT vs. IMRT and 3DCRT for Older Patients with Stage IIA Node-Negative Non-Small Cell Lung Cancer > 5 cm

Chemotherapy in elderly patients with nonsmall cell lung cancer

Atypical hemolytic uremic syndrome associated with Capnocytophaga canimorsus

The incorporation of cognitive-sparing techniques into prophylactic cranial irradiation in the management of small cell lung cancer

Adverse drug reaction: pomalidomide-induced liver injury

3363 Prognostic Value of Immune-Related Biomarkers in Resected Non-Small Cell Lung Cancer

Adjuvant treatment for elderly patients with early-stage lung cancer treated with limited resection

Abstract CT048: A Phase II trial of JDQ443 in KRAS G12C- mutated NSCLC with PD-L1 expression <1% or PD-L1 expression≥1% and an STK11 co-mutation

Outcomes following Stereotactic Body Radiotherapy vs. Limited Resection in Older Patients with Early Stage Lung Cancer

Adjuvant Treatment for Elderly Patients with Early Stage Lung Cancer Treated with Limited Resection

Adverse drug reaction: pomalidomide-induced liver injury

A phase II trial of JDQ443 in KRAS G12C -mutated NSCLC with PD-L1 expression <1% or PD-L1 expression ≥1% and an STK11 co-mutation

Real‐World longitudinal practice patterns in the use of PD‐1 and PD‐L1 inhibitors as First‐Line therapy in patients with Non‐Small cell lung cancer in the United States

KRAS G12C–Mutant Non–Small Cell Lung Cancer

Analysis of Real‐World Data to Investigate the Impact of Race and Ethnicity on Response to Programmed Cell Death‐1 and Programmed Cell Death‐Ligand 1 Inhibitors in Advanced Non‐Small Cell Lung Cancers

A phase 1b/2 trial of dupilumab given in conjunction with PD-(L)1 blockade in the treatment of relapsed/refractory metastatic NSCLC

Suchergebnisse filtern